Back to announcement
20250710_KLBF_Laporan Pengalihan Saham Hasil Buy Back_31913870.pdf
Other Text extracted KLBFSource file signed link, expires in 15 minutes
Extracted text 4
Page 1
Go To English Page Nomor Surat 178/CSEC-KF/VII-2025 Nama Perusahaan Kalbe Farma Tbk Kode Emiten KLBF Lampiran 1 Perihal Laporan Pengalihan Kembali Saham Hasil Buy Back Laporan Pelaksanaan Pengalihan Kembali Saham Hasil Buy Back Perseroan melaporkan pelaksanaan pengalihan saham hasil Buy Back untuk periode 19 Agustus 2022 Sebagai Berikut : Tanggal/Periode Transaksi 20 April 2025 Anggota Bursa Pelaksana (jika relevan) - Jumlah saham hasil buy back yang dijual/dialihkan 61.730.570 Harga rata-rata 0 Jumlah dana yang diperoleh 0 Kerugian dari Penjualan/Pengalihan (jika relevan) 0 Nama pihak yang membeli saham hasil Buy Back (jika relevan) - Dengan pelaksanaan pengalihan kembali saham Perseroan hasil Buy Back, maka akumulasi pengalihan kembali saham hasil Buy Back adalah sebagai berikut : Jumlah saham hasil Buy Back yang telah dijual/dialihkan 61.730.570 Jumlah dana yang diperoleh 0 Kerugian dari Penjualan/Pengalihan (jika relevan) 0 Jumlah Saham hasil buy back yang belum dialihkan 555.575.130 Informasi Lain Jumlah saham hasil buyback yang belum dialihkan sejumlah 555.575.130 saham adalah berdasarkan buyback yang dilakukan untuk periode 19 Agustus 2022. Adapun untuk periode buyback lainnya adalah sebagaimana disampaikan pada Lampiran Form ini. Demikian untuk diketahui. Hormat Kami, Kalbe Farma Tbk Maria Teresa Fabiola Corporate Secretary Kalbe Farma Tbk
Page 2
Nama Pengirim Maria Teresa Fabiola
Jabatan Corporate Secretary
Tanggal dan Waktu 10-07-2025
Lampiran 1. KLBF - Laporan Pengalihan Saham Hasil Buy Back.pdf
Dokumen ini merupakan dokumen resmi Kalbe Farma Tbk yang tidak memerlukan tanda tangan karena dihasilkan
secara elektronik oleh sistem pelaporan elektronik. Kalbe Farma Tbk bertanggung jawab penuh atas informasi yang
tertera didalam dokumen ini.
Page 3
Go To Indonesian Page Letter / Announcement No. 178/CSEC-KF/VII-2025 Issuer Name Kalbe Farma Tbk Issuer Code KLBF Attachment 1 Subject Report of Shares Transfer From Shares Buy Back Report of Transfer of Shares Buy Back The Company reported the execution of Buy Back for the period 19 August 2022 as follows : Date/Transaction Period 20 April 2025 Exchange Member (if relevant) - Number shares of buy back sold/transferred 61.730.570 Average sales / transfer price 0 Amount of fund raised 0 Loss on sale / transfer (if relevant) 0 Buyers name of shares buy back - With the execution of transfer shares buy back, the accumulation of the transfer of shares Buyback results as follows: The number of shares Buyback that have been sold / transferred 61.730.570 Amount of fund raised 0 Loss on sale / transfer (if relevant) 0 Remaining shares buy back 555.575.130 Other Information: The number of shares resulting from the buyback that have not yet been transferred, amounting to 555,575,130 shares, is based on the buyback conducted for the period of August 19, 2022. As for other buyback periods, the details are as set out in the Appendix to this Form. Thus to be informed accordingly. Respectfully, Kalbe Farma Tbk Maria Teresa Fabiola Corporate Secretary Kalbe Farma Tbk
Page 4
Sender Name Maria Teresa Fabiola
Function Corporate Secretary
Date and Time 10-07-2025
Attachment
This is an official document of Kalbe Farma Tbk that does not require a signature as it was generated electronically
by the electronic reporting system. Kalbe Farma Tbk is fully responsible for the information contained within this
document.
Names mentioned 2 people and organisations named in the text · linked when the evidence is strong
unresolved
org
Maria Teresa Fabiola
· Corporate Secretary
p.1 ×3
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.